Central laboratory

FVIII levels and FVIII inhibitor titres are key parameters for assessing treatment outcomes in MOTIVATE

To investigate the impact of different treatment approaches on FVIII inhibitor titres and FVIII plasma levels, it is important that measurements are performed consistently for different patients. Performing the measurements at a single central laboratory may help to enable this.

Central laboratory

Participating centres have the opportunity to send samples to a central laboratory for FVIII and inhibitor measurements.

Central laboratory coordinators

whoweare CE profile v2

Carmen Escuriola-Ettingshausen

Director, HZRM Hämophilie-Zentrum Rhein Main,
Mörfelden-Walldorf, Germany

whoweare GY profile v2

Guy Young

Director, Hemostasis and Thrombosis Program, Children's Hospital Los Angeles,
Los Angeles, CA, US

Front2 1

Contact